Usana Health Sciences (USNA) Debt to Equity (2016 - 2025)
Historic Debt to Equity for Usana Health Sciences (USNA) over the last 6 years, with Q1 2025 value amounting to $0.04.
- Usana Health Sciences' Debt to Equity rose 154449.55% to $0.04 in Q1 2025 from the same period last year, while for Mar 2025 it was $0.04, marking a year-over-year increase of 154449.55%. This contributed to the annual value of $0.04 for FY2024, which is 263424.58% up from last year.
- Usana Health Sciences' Debt to Equity amounted to $0.04 in Q1 2025, which was up 154449.55% from $0.04 recorded in Q4 2024.
- Usana Health Sciences' 5-year Debt to Equity high stood at $0.04 for Q1 2025, and its period low was $0.0 during Q4 2023.
- Moreover, its 4-year median value for Debt to Equity was $0.03 (2022), whereas its average is $0.02.
- In the last 5 years, Usana Health Sciences' Debt to Equity soared by 263424.58% in 2024 and then skyrocketed by 154449.55% in 2025.
- Usana Health Sciences' Debt to Equity (Quarter) stood at $0.03 in 2022, then tumbled by 93.84% to $0.0 in 2023, then skyrocketed by 2634.25% to $0.04 in 2024, then increased by 0.44% to $0.04 in 2025.
- Its last three reported values are $0.04 in Q1 2025, $0.04 for Q4 2024, and $0.0 during Q1 2024.